Upcom­ing HERA call under EU4Health – Rapid point-of-care antimi­cro­bial sus­cep­ti­bil­i­ty test­ing diag­nos­tic med­ical device

The Euro­pean Health Emer­gency Pre­pared­ness and Response Author­i­ty (HERA) has announced a new call for pro­pos­als under the EU4Health pro­gram, aimed at enhanc­ing Europe’s pre­pared­ness against health threats. This fund­ing oppor­tu­ni­ty focus­es on rapid antimi­cro­bial sus­cep­ti­bil­i­ty test­ing diag­nos­tics. With a sig­nif­i­cant bud­get allo­ca­tion, this ini­tia­tive seeks to fos­ter inno­va­tion in med­ical coun­ter­mea­sures, strength­en pub­lic health strate­gies, and ensure faster respons­es to emerg­ing health crises.

Researchers, biotech firms, and health­care stake­hold­ers are encour­aged to sub­mit their pro­pos­als before the dead­line.

Devel­op­ment of a rapid point-of-care antimi­cro­bial sus­cep­ti­bil­i­ty test­ing diag­nos­tic med­ical device

Scope: This call for ten­ders seeks to accel­er­ate the devel­op­ment of rapid point-of-care diag­nos­tic devices pro­vid­ing antimi­cro­bial sus­cep­ti­bil­i­ty results with­in one hour, ide­al­ly with pathogen iden­ti­fi­ca­tion, tar­get­ing pri­or­i­ty bac­te­r­i­al and fun­gal pathogens, pro­gress­ing from TRL 3+ towards CE mark­ing and TRL 8 qual­i­fi­ca­tion. This is a com­pet­i­tive pro­ce­dure with nego­ti­a­tion with a max­i­mum con­tract dura­tion of 48 months.

Dead­line for receipt of requests to par­tic­i­pate: 12.5.2025 16:00 Europe/Brussels

Esti­mat­ed total val­ue:  EUR 12.86Mio

Read more: PoC AMR/AST Diag­nos­tic Device F&Ts Appli­ca­tion Web­page

Source: Busi­ness Fin­land
Image: Poli­na Tankile­vitch